| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.45 | 0.009 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.009 |